Posted innews Otorhinolaryngology Rheumatology
Exploring Janus Kinase Inhibition as a Novel Therapeutic Avenue in Idiopathic Subglottic Stenosis
JAK inhibitors, proven in rheumatoid arthritis, show potential in extending surgical-free intervals and reducing dilation frequency in idiopathic subglottic stenosis by targeting immune-mediated fibroinflammation.
